Previous Article | Next Article ![]()
Journal of Virology, February 2000, p. 1114-1123, Vol. 74, No. 3
Centro de Investigación en Sanidad
Animal (CISA-INIA), Valdeolmos, 28130 Madrid,1
Departamento de Bioquímica y Biología
Molecular, Instituto Universitario de Biotecnología de Asturias
(CSIC), Universidad de Oviedo, 33006 Oviedo,2
Departamento de Patología Animal, Facultad de
Veterinaria, Universidad de Zaragoza,
Zaragoza,3 and Laboratorios Hipra
S.A. Amer., 1710 Girona,4 Spain
Received 1 July 1999/Accepted 1 November 1999
We have developed a new strategy for immunization of wild rabbit
populations against myxomatosis and rabbit hemorrhagic disease (RHD)
that uses recombinant viruses based on a naturally attenuated field
strain of myxoma virus (MV). The recombinant viruses expressed the RHDV
major capsid protein (VP60) including a linear epitope tag from the
transmissible gastroenteritis virus (TGEV) nucleoprotein. Following
inoculation, the recombinant viruses induced specific antibody
responses against MV, RHDV, and the TGEV tag. Immunization of wild
rabbits by the subcutaneous and oral routes conferred protection
against virulent RHDV and MV challenges. The recombinant viruses showed
a limited horizontal transmission capacity, either by direct contact or
in a flea-mediated process, promoting immunization of contact
uninoculated animals.
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Horizontal Transmissible Protection against
Myxomatosis and Rabbit Hemorrhagic Disease by Using a Recombinant
Myxoma Virus
*
Corresponding author. Mailing address: Centro de
Investigación en Sanidad Animal (CISA-INIA), Valdeolmos, 28130 Madrid, Spain. Phone: 34-91-620 23 00. Fax: 34-91-620 22 47. E-mail:
jmtorres{at}inia.es.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|